Literature DB >> 28449349

Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.

Stefan Lohse1, Sebastian Loew1, Anna Kretschmer1, J H Marco Jansen2, Saskia Meyer2, Toine Ten Broeke2, Thies Rösner1, Michael Dechant3, Stefanie Derer1, Katja Klausz1, Christian Kellner1, Ralf Schwanbeck1, Ruth R French4, Thomas R W Tipton4, Mark S Cragg4, Denis M Schewe5, Matthias Peipp1, Jeanette H W Leusen2, Thomas Valerius1.   

Abstract

Entities:  

Keywords:  ADCC; CD20; IgA antibody; antibody therapy; myeloid effector cells

Mesh：

Substances：

Year:  2017        PMID： 28449349     DOI： 10.1111/bjh.14624

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  14 in total

Review 1.  Antibody-dependent cellular cytotoxicity in HIV infection.

Authors:  Donald N Forthal; Andrés Finzi
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 2.  Antibody Isotypes for Tumor Immunotherapy.

Authors:  Anna Kretschmer; Ralf Schwanbeck; Thomas Valerius; Thies Rösner
Journal:  Transfus Med Hemother       Date:  2017-09-07       Impact factor: 3.747

3.  Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma.

Authors:  Sandra Lara; Juliane Heilig; Alexander Virtanen; Sandra Kleinau
Journal:  BMC Cancer       Date:  2022-06-20       Impact factor: 4.638

4.  The selection of variable regions affects effector mechanisms of IgA antibodies against CD20.

Authors:  Mitchell Evers; Thies Rösner; Anna Dünkel; J H Marco Jansen; Niklas Baumann; Toine Ten Broeke; Maaike Nederend; Klara Eichholz; Katja Klausz; Karli Reiding; Denis M Schewe; Christian Kellner; Matthias Peipp; Jeanette H W Leusen; Thomas Valerius
Journal:  Blood Adv       Date:  2021-10-12

Review 5.  Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Authors:  Michael J E Marshall; Richard J Stopforth; Mark S Cragg
Journal:  Front Immunol       Date:  2017-10-04       Impact factor: 7.561

Review 6.  Monoclonal antibody-mediated killing of tumour cells by neutrophils.

Authors:  Niels Heemskerk; Marjolein van Egmond
Journal:  Eur J Clin Invest       Date:  2018-07-05       Impact factor: 4.686

Review 7.  IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.

Authors:  Annelot Breedveld; Marjolein van Egmond
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

8.  Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.

Authors:  Arianne M Brandsma; Sina Bondza; Mitchell Evers; Rosanne Koutstaal; Maaike Nederend; J H Marco Jansen; Thies Rösner; Thomas Valerius; Jeanette H W Leusen; Toine Ten Broeke
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

Review 9.  IgA: Structure, Function, and Developability.

Authors:  Patrícia de Sousa-Pereira; Jenny M Woof
Journal:  Antibodies (Basel)       Date:  2019-12-05

Review 10.  Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance.

Authors:  Charita Furumaya; Paula Martinez-Sanz; Panagiota Bouti; Taco W Kuijpers; Hanke L Matlung
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.